Migraine in Poland - a Web-based Cross-sectional Survey

Migraine Clinical Trial

— MIGinPOL2021  

Official title:

Migraine in Poland - a Web-based Cross-sectional Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05087420
• Other study ID #: MIGinPOL2021
• Status: Completed
• Start date: September 1, 2021
• Est. completion date: April 30, 2022

Study information

• Verified date: May 2022
• Source: Swiat Zdrowia
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2800
• Est. completion date: April 30, 2022
• Est. primary completion date: April 30, 2022
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• consent to participate in the study

Exclusion Criteria:

• responses missing in questionnaire

Related Conditions & MeSH terms

• Migraine
• Migraine Disorders

Locations

Country	Name	City	State
Poland	Marcin Straburzynski	Dzwierzuty	Warminsko-mazurskie
Poland	Department of Neurology, Wroclaw Medical University	Wroclaw

Sponsors (2)

Lead Sponsor	Collaborator
Swiat Zdrowia	Wroclaw Medical University

Country where clinical trial is conducted

Poland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Headache phenotype	Classification of reported headache according to International Classification of Headache Disorders	in the preceding year
Primary	Migraine burden	Consequences of the disease measured by the Migraine Disability Assessment Test	in the preceding year
Secondary	Monthly headache days	Number of days per month	in the preceding month
Secondary	Monthly headache days	Number of days per year	in the preceding year
Secondary	Time from last headache professional consultation	Number of months	in the preceding 10 years
Secondary	Migraine diagnosed by headache professional	yes/no	in the preceding 10 years
Secondary	Age at diagnosis	years	from the onset of headache (time frame up to 99 years)
Secondary	Comoribidities	Disease according to International Classsification of Disease 10	in the preceding year
Secondary	Type of previous headache professional consultation	Name of headache profession/speciality	in the preceding 10 years
Secondary	Number of consultations in the last year	Number 0-100	in the last 12 months
Secondary	Number of consultations in the last year because of headaches	Number 0-100	in the last 12 months
Secondary	Number of days spent in hospital in the last year because of headaches	Number 0-100	in the last 12 months
Secondary	Acute treatment used	Name of abortive medication	in the preceding 10 years
Secondary	Preventive treatment used	Name of abortive medication	in the preceding 10 years
Secondary	Acute treatment frequency	Number of days per month	in the last 3 months
Secondary	Preventive treatment frequency	Number of months form the last dose	in the last 12 months
Secondary	Preventive treatment effectiveness	Likert scale	in the last 12 months
Secondary	Employment	Type of employment	in the last 12 months
Secondary	Time spent at work	Number of hours per week	in the last 12 months
Secondary	Work absence due to headache	Number of days per month	in the last month
Secondary	Presenteeism	Number of days per month	in the last month
Secondary	PHQ-9 Patient Health Questionnaire	Number	in the last 2 weeks
Secondary	Sinus headache	Number of days	in the last 3 months
Secondary	Sinonasal symptoms accompanying headache	Type of symptoms	in the last 12 months
Secondary	Sinonasal symptoms not associated with headache	Type of symptom	in the last 12 months
Secondary	COVID-19 association with headache	Likert scale	in the last 2 years
Secondary	COVID-19 vaccine association with headache	Likert scale	in the last year

External Links

•   Questionnaire link